JNC VI guidelines.
作者信息
Green L
出版信息
Lancet. 1998 Jan 24;351(9098):288-9; author reply 289-90. doi: 10.1016/S0140-6736(98)26004-1.
PMID:9457118
Abstract
摘要
相似文献
1
JNC VI guidelines.
Lancet. 1998 Jan 24;351(9098):288-9; author reply 289-90. doi: 10.1016/S0140-6736(98)26004-1.
2
JNC-7 versus renin-based strategies for optimal antihypertensive drug treatment. Another look at the evidence.
Am J Hypertens. 2004 Oct;17(10):1002-4. doi: 10.1016/j.amjhyper.2004.08.002.
3
JNC 8 uses evidence-based methodology in new guideline on hypertension management.
Med Econ. 2014 Jun 10;91(11):20.
4
JNC VI guidelines.
Lancet. 1998 Jan 24;351(9098):288; author reply 289-90. doi: 10.1016/S0140-6736(05)78247-7.
5
Adherence to the JNC VI guidelines for the treatment of hypertension in the resident clinic.
Md Med J. 1999 Nov-Dec;48(6):307-11.
6
Developing hypertension guidelines: an evolving process.
Am J Hypertens. 2014 Jun;27(6):765-72. doi: 10.1093/ajh/hpt298. Epub 2014 Feb 26.
7
Staying up to date with the JNC 8 hypertension guideline.
JAAPA. 2014 Aug;27(8):44-9. doi: 10.1097/01.JAA.0000451865.17954.9b.
8
Outcomes trials underlying the JNC-7 guidelines.
Manag Care. 2003 Aug;12(8 Suppl Hypertension):20-5.
9
[Guidelines for the treatment of arterial hypertension: evidence, consensus and gray areas].
G Ital Cardiol. 1997 Nov;27(11):1187-92.
10
Generalizability of guidelines and physicians' adherence. Case study on the Sixth Joint National Commitee's guidelines on hypertension.
BMC Public Health. 2003 Jul 21;3:24. doi: 10.1186/1471-2458-3-24.
Zotero 插件